XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($)
Common stock issued
Donated shares
Additional paid-in capital
Statutory reserves
Accumulated deficit
Accumulated other comprehensive Income (loss)
Non- controlling interests
Treasury shares
Total
Balance at Dec. 31, 2022 $ 89,135   $ 246,240,998 $ 1,230,511 $ (131,946,705) $ (8,153,644) $ 6,883,123 $ (4,066,610) $ 124,378,497
Balance (in Shares) at Dec. 31, 2022 89,135,064 14,101,689           (144,206)  
Net income (loss)   (1,380,355) (824,127) (2,204,482)
Share-based compensation for employee and director stock awards   4,897 4,897
Common stock issued to employees for stock award $ 16   (16)
Common stock issued to employees for stock award (in Shares) 16,667            
Foreign currency translation adjustment   654,673 94,106 748,779
Balance at Mar. 31, 2023 $ 89,151   246,245,879 1,230,511 (133,327,060) (7,498,971) 6,153,102 $ (4,066,610) 122,927,691
Balance (in Shares) at Mar. 31, 2023 89,151,731 14,101,689           (144,206)  
Balance at Dec. 31, 2023 $ 90,063   247,465,817 1,230,511 (134,395,762) (11,601,403) 634,036 $ (4,066,610) $ 113,458,341
Balance (in Shares) at Dec. 31, 2023 90,063,396 14,101,689           (144,206) 90,063,396
Net income (loss)     9,836,450 (263,976) $ 9,572,474
Share-based compensation for employee and director stock awards   116,582 116,582
Foreign currency translation adjustment   (1,895,801) (10,247) (1,906,048)
Balance at Mar. 31, 2024 $ 90,063   $ 247,582,399 $ 1,230,511 $ (124,559,312) $ (13,497,204) $ 359,813 $ (4,066,610) $ 121,241,349
Balance (in Shares) at Mar. 31, 2024 90,063,396 14,101,689           (144,206) 89,919,190